ID: MRFR/MED/4972-HCR | February 2021 | Region: Global | 100 pages
Flow Cytometry Market Scenario
The flow cytometry market is expected to grow during the forecast period (2018–2023) at a CAGR 11.5%. Flow cytometry is used to determine the physical and chemical characteristics of a cell or a particle. Flow cytometry of a cell can determine the cell size, cell count, cell cycle and other characteristics of the cell. It helps scientists and researchers to extract specific information about the cell or particle. The increasing use of flow cytometry in diagnosis, increasing applications of flow cytometry in healthcare research and growing adoption of new technology are responsible for the growth of the market. Moreover, the rising prevalence of HIV/AIDS and cancer cases are contributing to the growth of the flow cytometry market. According to the UNAIDS, in the year 2015 more than 36.7 million people worldwide were affected by HIV/AIDS and out of which 1.8 million were children below 15 yrs.
The high costs of flow cytometry instruments and reagents, lack of awareness about applications of flow cytometry and scarcity of technicians may hamper the growth of the market during the assessment period.
The flow cytometry market has been segmented on the basis of products & services, technology, application, and end-user.
On the basis of products & services, the market has been classified as reagents and consumables, flow cytometry instruments, services, software, and accessories. The flow cytometry instruments segment has been further divided into cell analyzers and cell sorters.
The market by technology has been divided into cell-based flow cytometry and bead-based flow cytometry.
The application segment has been divided into research applications, clinical applications, and industrial applications. The research applications segment has been segmented into pharmaceutical and biotechnology and immunology. The pharmaceutical and biotechnology sub-segment has been divided into drug discovery, stem cell research, and in vitro toxicity testing. Furthermore, the immunology segment has been sub-segmented into cell sorting, apoptosis, cell cycle analysis, cell viability, cell counting, and other research applications. The clinical applications segment includes cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.
The market, by end-user, has been segmented into commercial, research institutes, hospitals and clinics, and academic institutes.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The flow cytometry market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European flow cytometry market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The flow cytometry market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
Flow Cytometry Market Share, by Region, 2017 (%)
Source: MRFR Analysis
The Americas are likely to dominate the flow cytometry market owing to the presence of a well-established healthcare system, adoption of highly advanced technology and increase in the number of patients suffering from autoimmune diseases in the region and with that the increase in the use of flow cytometry for diagnostics purpose. According to the American Autoimmune Related Diseases Association, more than 50 million Americans are suffering from autoimmune diseases and autoimmune disease is one of the top ten causes of death in women and children.
The European market is expected to be the second-largest flow cytometry market. The market growth in this region can be attributed to government funding and support to the research and development activities, raising awareness about healthcare diagnostics and increasing cases of cancer patients in the region. Moreover, increasing research and development activities in the pharmaceutical industry is contributing to the growth of the market in this region. For instance, according to the European Federation of Pharmaceutical Industries and Associations, in the year 2015, the European pharmaceutical sector has invested more than USD 33,557 million in research and development activities.
Asia-Pacific is expected to be the fastest-growing flow cytometry market during the forecast period owing to the increasing prevalence of autoimmune diseases, increasing awareness about healthcare and rising investments and collaborative activities in healthcare and expansions by market players in the region. For instance, in June 2017, Beckman Coulter, Inc. entered into extensive distribution agreement with Grifols S.A to expand its diagnostics portfolio.
The market in the Middle East & Africa is expected to account for the smallest share of the flow cytometry market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.
Some of the key players in the flow cytometry are Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH, Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc.
Flow Cytometry Market, by Products & Services
Flow Cytometry Market, by Technology
Flow Cytometry Market, by Application
Flow Cytometry Market, by End-User
Flow Cytometry Market, by Region
Middle East & Africa
|Market Size||2027: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product & service, Technology, Applications, End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH, Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc.|
|Key Market Opportunities||Rising prevalence of HIV/AIDS and cancer cases|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
The clinical applications segment includes cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.
Costly instruments and lack of awareness & skilled technicians can be taken as major market hurdles.
The segments are clinical applications, research applications, and industrial applications.
The end users are hospitals & clinics, research institutes, commercial, and academic institutes.
The Americas would ensure strong growth for the market.
Flow cytometry market would record 11.5% during the forecast period of 2018-2023.